Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2010

Dec 15, 2010

33081_dirs_2010-12-15_de79f0b8-e8f7-405e-a7f3-a3decccdcf1e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VENTRUS BIOSCIENCES INC (VTUS)
CIK: 0001426800
Period of Report: 2010-12-15

Reporting Person: Felder Joseph (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (right to buy) $ 2020-05-11 Common Stock (2016) Direct
Stock Options (right to buy) $ 2020-11-10 Common Stock (35000) Direct

Footnotes

F1: The price is equal to the lowest price paid in the issuer's next qualified equity financing (as defined in the issuer's
existing 2010 Convertible Promissory Notes).

F2: The options vested 1/3 on 5/28/2008 and the remaining 2/3 will vest in equal installments on the first, second and third
anniversaries after 05/28/2008.